Filter Results
:
(44)
Show Results For
-
All HBS Web
(89)
- News (30)
- Research (44)
- Multimedia (2)
- Faculty Publications (24)
Show Results For
-
All HBS Web
(89)
- News (30)
- Research (44)
- Multimedia (2)
- Faculty Publications (24)
Sort by
- December 2019
- Case
Noiler
By: José B. Alvarez and Natalie Kindred
In 2019, Nigerian entrepreneur Dr. Ayoola (Ayo) Oduntan is accelerating distribution of Noiler, a genetically optimized breed of poultry, to smallholder farmers across Nigeria. The bird was bred to be productive as a source of both meat and eggs and to thrive in the...
View Details
- November 2019 (Revised February 2020)
- Case
Hormel Foods
By: David E. Bell and Natalie Kindred
In 2019, CEO Jim Snee is weighing how to shape the image of Hormel Foods, one of the largest U.S. meat and food companies, at a time when the industry faces unprecedented scrutiny. Based in the small town of Austin, Minnesota, the nearly 130-year-old firm is best known...
View Details
Keywords:
Brand Portfolio Strategy;
Brands and Branding;
Product;
Strategy;
Marketing Strategy;
Risk Management;
Agriculture and Agribusiness Industry;
Food and Beverage Industry;
Consumer Products Industry;
United States;
China
Bell, David E., and Natalie Kindred. "Hormel Foods." Harvard Business School Case 520-045, November 2019. (Revised February 2020.)
- February 2022 (Revised July 2022)
- Supplement
InstaDeep: AI Innovation Born in Africa (B)
By: Shikhar Ghosh and Esel Çekin
Karim Beguir and Zohra Slim were the co-founders of InstaDeep, a deep tech startup focusing on artificial intelligence (AI) solutions. Instadeep was one of the few companies globally that were partnering with DeepMind, an AI subsidiary of Google [Alphabet Inc.]....
View Details
Keywords:
AI;
Artificial Intelligence;
Entrepreneurship;
Operations;
Business Subsidiaries;
Brands and Branding;
Innovation and Invention;
Growth and Development Strategy;
AI and Machine Learning;
Technology Industry;
Africa
Ghosh, Shikhar, and Esel Çekin. "InstaDeep: AI Innovation Born in Africa (B)." Harvard Business School Supplement 822-105, February 2022. (Revised July 2022.)
- January 2020
- Case
Celata Bioinnovations
By: John R. Wells and Benjamin Weinstock
In December 2019, Jon Hu (HBS ‘19) and Dr. Samantha Dale Strasser, co-founders of Celata Bioinnovations, were raising $1 million to launch their company. They had founded Celata less than six months earlier with the aim of redefining the drug discovery process....
View Details
Keywords:
Drug Development;
Drug Discovery;
Drug Trials;
Pharmaceutical Companies;
Pharmaceutical Company;
Pharmaceuticals;
Therapeutics;
Biologics;
Biotech;
Biotechnology;
Biopharmacy Company;
Biochemistry;
Technology Commercialization;
Technology Companies;
Drug Testing;
Startup;
Start-up;
Startups;
Start-ups;
Startup Financing;
Strategic Decision Making;
Strategic Decisions;
Strategic Evolution;
FDA;
Food And Drug Administration;
Clinical Trials;
Disease Management;
Market Attractiveness;
Market Entry;
Market Opportunities;
Health Disorders;
Technological Innovation;
Information Technology;
Commercialization;
Business Startups;
Finance;
Decision Making;
Strategy;
Market Entry and Exit;
Opportunities;
Pharmaceutical Industry;
Biotechnology Industry
Wells, John R., and Benjamin Weinstock. "Celata Bioinnovations." Harvard Business School Case 720-427, January 2020.
- 02 Jun 2022
- Research & Ideas
Blissful Thinking: When It Comes to Finding Happiness, 'Your Dreams Are Liars'
knowledge is directly applicable to your life, this combination becomes highly combustible. So, for instance, we can learn about the spike proteins on viruses, and then we can use that knowledge to create a vaccine to counter these...
View Details
Keywords:
by Dan Morrell
- 13 Jul 2020
- Research & Ideas
Merck CEO Ken Frazier Discusses a COVID Cure, Racism, and Why Leaders Need to Walk the Talk
recent vaccine for Ebola took five and a half years. And why does it take so long? First of all, it requires a rigorous scientific assessment. And here we didn't even understand the virus itself or how the virus affects the immune system. We're starting there. We're...
View Details
- 26 Jun 2017
- Research & Ideas
How Cellophane Changed the Way We Shop for Food
derivatives of the protein myoglobin. When the meat is first cut, it looks purple. After being exposed to oxygen for half an hour or so, it looks bright red. More time than that, and it begins to develop a brown color. While purple beef...
View Details
- 15 Nov 2018
- Book
Can the Global Food Industry Overcome Public Distrust?
JamesBrey Food is the largest segment of the global economy. It is also widely recognized as more critical for human health than any pharmaceutical drug on the planet. But significant changes in the industry are making people lose trust in many institutions involved in...
View Details
- 17 Oct 2016
- HBS Case
Business Solutions That Help Cut Food Waste
As much as 40 percent of food grown in the United States for human consumption is wasted. Source: Eivaisla After decades of wasteful food practices, where perfectly good food is discarded even as poverty keeps many families hungry, solutions are starting to come...
View Details
- 26 Mar 2019
- First Look
New Research and Ideas, March 26, 2019
company listed on the New Zealand stock exchange in 2018 by capitalizing on a biochemical discovery related to the protein composition of cow's milk. Because many people find the A1 protein difficult to...
View Details
Keywords:
Dina Gerdeman
- 29 May 2001
- Research & Ideas
Genomics: Can We Start Making Money Now?
couple of years to start getting traction on the data that has been published. Also, it will require significant investments in research to fill in all the "blank spots" in discovering how genes interact with proteins to govern...
View Details
Keywords:
by Sean Silverthorne
- 10 Nov 2014
- HBS Case
How Restaurants in Lima and Copenhagen Became Best in the World
each one wants to be known. Noma wasn't founded with the idea of bringing Danish food to the world; they wanted to bring Danish food to Denmark. At the same time, Noma wants to become part of the public discourse—how eating locally has other benefits or eating insects...
View Details
- 09 Sep 2014
- First Look
First Look: September 9
assessing the startup health care company's 2014 marketing plan. On December 31, 2013, Vaxess had obtained an exclusive license to a series of patents for a silk protein technology that, when added to vaccines, reduced or removed the need...
View Details
Keywords:
Sean Silverthorne
- 24 Mar 2015
- First Look
First Look: March 24
from clients; and perennial hiring challenges. Purchase this case: https://cb.hbsp.harvard.edu/cbmp/product/515011-PDF-ENG Harvard Business School Case 515-066 JBS JBS is a Brazilian protein company that started in beef, but has quickly...
View Details
Keywords:
Sean Silverthorne
- 03 Dec 2001
- Research & Ideas
Healthcare Conference Looks At Ailing Industry
proteins at work in the business of life. "The book of life" that made dramatic headlines last year—and was really a first draft of the human genome sequence—is destined to change and challenge medicine, ethics, and business far...
View Details
- 20 Mar 2012
- First Look
First Look: March 20
Business School Case 512-013 In mid-2011, the management of Brasil Foods, a leading Brazilian branded foods producer and protein exporter, is evaluating strategies for international and domestic growth. The team has just received approval...
View Details
Keywords:
Sean Silverthorne
- 01 Aug 2017
- First Look
First Look at New Research and Ideas, August 1
Scott Morton, Fiona, Ariel Dora Stern, and Scott Stern Abstract—Biologic drugs (therapeutic proteins or “large-molecule drugs”) represent a substantial and growing share of the U.S. drug market, accounting for less than 1% of...
View Details
Keywords:
Sean Silverthorne
- 09 Aug 2016
- First Look
August 9, 2016
https://pubwww.hbs.edu/faculty/Pages/item.aspx?num=51304 The Impact of the Entry of Biosimilars: Evidence from Europe By: Scott Morton, Fiona, Ariel Dora Stern, and Scott Stern Abstract—Biologic drugs (therapeutic proteins or...
View Details
Keywords:
Sean Silverthorne
- 20 Nov 2006
- Research & Ideas
Open Source Science: A New Model for Innovation
The best toxicologists within the firm had a look at the results and couldn't understand them. Their external academic consultants, also toxicologists, also failed to interpret the results. Then they finally posted it onto InnoCentive. A View Details
Keywords:
by Martha Lagace